Skip to content
Screener

10x Genomics, Inc. TXG United States — Revenue

Other geography segments

China
$23.17M

Similar metrics at other companies

Credo Technology Group Holding Ltd logo
CRDOUnited States — Revenue
$314.12M+1,166%
Ameresco logo
AMRCUnited States — Revenue
$240.37M+3.3%
CBIZ logo
CBZUnited States — Revenue
$689.04M+52.2%
Alpha and Omega Semiconductor logo
AOSLUNITED STATES — Revenue
$2.15M+84.3%
Braze, Inc. logo
BRZEUnited States — Revenue
$115.51M+31.4%
Asana logo
ASANUnited States — Revenue
$120.32M+7.9%

Other financials

Income statement

See full
Revenue$151.0M-12.6%
Gross profit$112.5M-10.1%
Operating income-$19.6M-165%
Net income-$17.9M-152%
EPS (diluted)-$0.14-150%

Balance sheet

See full
Cash & equivalents$502.5M+26.4%
Total debt$78.8M-9.2%
Total equity$825.5M+6.8%
Total assets$1.0B+5.1%

Cash flow

See full
Operating cash flow$17.0M-4.1%
CapEx$1.6M+0.6%
Free cash flow$15.4M-4.6%

Valuation

See full
Market cap$5.79B+271%
Enterprise value$5.37B+330%
P/S9.4×+7.0×

Profitability

See full
Gross margin70%+0.5pp
Operating margin-14.3%-1.1pp
Net margin-12.2%-0.8pp
FCF margin19.7%+10.9pp

Returns & leverage

See full
Return on equity-9.4%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.7×-0.1×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054491
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Americas
United States(1)$82,109$103,491$158,802$190,309
Americas (excluding United States)2,9172,6676,3236,419
Total Americas85,026106,158165,125196,728
Europe, Middle East and Africa39,97234,73476,82466,629
Asia-Pacific
China14,96823,17030,80540,053
Asia-Pacific (excluding China)11,0708,84629,12524,381

Item 1. Financial Statements (Unaudited)

FAQ

What is 10x Genomics, Inc.'s united states — revenue?
10x Genomics, Inc. (TXG) reported united states — revenue of $82.11M in Q2 2026.
How has 10x Genomics, Inc.'s united states — revenue changed year-over-year?
10x Genomics, Inc.'s united states — revenue decreased by 20.7% year-over-year, from $103.49M to $82.11M.
What is the long-term trend for 10x Genomics, Inc.'s united states — revenue?
Over 4 years (2021 to 2025), 10x Genomics, Inc.'s united states — revenue has grown at a 7.6% compound annual growth rate (CAGR), from $258.27M to $346.51M.
What does united states — revenue mean?
This metric represents the total revenue generated from sales of instruments, consumables, and software within the United States geographic market. It serves as a primary indicator of the company's market penetration and demand for life science technology solutions in its largest domestic region. Monitoring this figure helps investors assess regional growth trends and the effectiveness of local commercial operations.

Ask your AI about 10x Genomics, Inc.'s united states — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude